Cargando…

Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models()

Elevated folate receptor alpha (FRα) expression is characteristic of epithelial ovarian cancer (EOC), thus establishing this receptor as a candidate target for the development of novel therapeutics to treat this disease. Mirvetuximab soravtansine (IMGN853) is an antibody-drug conjugate (ADC) that ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponte, Jose F., Ab, Olga, Lanieri, Leanne, Lee, Jenny, Coccia, Jennifer, Bartle, Laura M., Themeles, Marian, Zhou, Yinghui, Pinkas, Jan, Ruiz-Soto, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126132/ https://www.ncbi.nlm.nih.gov/pubmed/27889646 http://dx.doi.org/10.1016/j.neo.2016.11.002

Ejemplares similares

Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
por: Gonzalez-Ochoa, Eduardo, et al.
Publicado: (2023)

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
por: Matulonis, Ursula A., et al.
Publicado: (2023)

Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
por: Martin, Lainie P., et al.
Publicado: (2017)

The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models
por: Hicks, Stuart W., et al.
Publicado: (2017)

Peptide-Cleavable Self-immolative Maytansinoid Antibody–Drug Conjugates Designed To Provide Improved Bystander Killing
por: Costoplus, Juliet A., et al.
Publicado: (2019)

Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors
por: Shah, Manisha H., et al.
Publicado: (2016)

CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia
por: Angelova, Evgeniya, et al.
Publicado: (2019)

Structural Basis for the Inhibition of the Autophosphorylation Activity of HK853 by Luteolin
por: Zhou, Yuan, et al.
Publicado: (2019)

Correction to Lancet Rheumatol 2022; 4: e853–63
Publicado: (2023)

The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model
por: Beckwith, Kyle A., et al.
Publicado: (2014)

PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN
por: Pemmaraju, N., et al.
Publicado: (2022)

853. Epidemiology of Groups A, C, and G β-Hemolytic Streptococcal Pharyngitis
por: Lim, James Ray Mata, et al.
Publicado: (2019)

Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate
por: Brand, Christian, et al.
Publicado: (2018)

A step-wise synthetic approach is necessary to access γ-conjugates of folate: folate-conjugated prodigiosenes
por: Figliola, Carlotta, et al.
Publicado: (2019)

Is there a genetic cause of appetite loss?—an explorative study in 1,853 cancer patients
por: Solheim, Tora S., et al.
Publicado: (2012)

Run 853, 26 GeV, 28.6.77, Circulating beams with SFM off
por: Hoffmann, H
Publicado: (1977)

S139: INTERIM ANALYSIS OF A REGISTRATION ENABLING STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) A CD123-TARGETING ANTIBODY-DRUG CONJUGATE, IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)
por: Pemmaraju, Naveen, et al.
Publicado: (2023)

Functional coating of liposomes using a folate– polymer conjugate to target folate receptors
por: Watanabe, Kazuo, et al.
Publicado: (2012)

Safety, tolerability, and preliminary activity of IMGN529, a CD37-targeted antibody-drug conjugate, in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: a dose-escalation, phase I study
por: Stathis, Anastasios, et al.
Publicado: (2018)

853. Hospital-acquired Infections by Vancomycin-Resistant Enterococcus (VRE): Results in 3 Years of Multicenter Study
por: Tanure, Luciana Coelho, et al.
Publicado: (2020)

PTPN11 c.853T>C (p.Phe285Leu) mutation in Noonan syndrome with chylothorax
por: Watanabe, Daisuke, et al.
Publicado: (2022)

Run 853, 27th June 1977, 26 GeV, Measurements with the clearing current monitor in octant 4
por: Gröbner, Oswald, et al.
Publicado: (1977)

Assay method for quality control and stability studies of a new anti-diabetic and anti-dyslipidemic flavone (S002-853)*
por: Naqvi, Arshi, et al.
Publicado: (2015)

Pharmacological therapies for infantile hemangiomas: A clinical study in 853 consecutive patients using a standard treatment algorithm
por: Zhang, Ling, et al.
Publicado: (2016)

Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses Adipogenesis
por: Hinds, Terry D., et al.
Publicado: (2016)

The Sex Ratio at Birth for 5,338,853 Deliveries in China from 2012 to 2015: A Facility-Based Study
por: Huang, Yan, et al.
Publicado: (2016)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

Associations between novel anthropometric measures and the prevalence of hypertension among 45,853 adults: A cross-sectional study
por: Wu, Li-Da, et al.
Publicado: (2022)

Investigation of folate-conjugated fluorescent silica nanoparticles for targeting delivery to folate receptor-positive tumors and their internalization mechanism
por: Yang, Hong, et al.
Publicado: (2011)

Facile synthesis of folate-conjugated magnetic/fluorescent bifunctional microspheres
por: Shen, Mao, et al.
Publicado: (2014)

Folate-conjugated polyspermine for lung cancer–targeted gene therapy
por: Zhang, Mei, et al.
Publicado: (2016)

Enhancement of Binding Affinity of Folate to Its Receptor by Peptide Conjugation
por: Dharmatti, Roopa, et al.
Publicado: (2019)

Imaging of Folate Receptor Expressing Macrophages in the Rat Groove Model of Osteoarthritis: Using a New DOTA-Folate Conjugate
por: de Visser, Huub M., et al.
Publicado: (2017)

Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation
por: Hinds, Terry D, et al.
Publicado: (2014)

Brain Uptake of Folate Forms in the Presence of Folate Receptor Alpha Antibodies in Young Rats: Folate and Antibody Distribution
por: Bobrowski-Khoury, Natasha, et al.
Publicado: (2023)

Synthesis and Evaluation of Folate-Conjugated Phenanthraquinones for Tumor-Targeted Oxidative Chemotherapy
por: Kumar, Ajay, et al.
Publicado: (2016)

Targeted images of KB cells using folate-conjugated gold nanoparticles
por: Rathinaraj, Pierson, et al.
Publicado: (2015)

Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs
por: Feng, Shini, et al.
Publicado: (2016)

Morphine immunomodulation prolongs inflammatory and postoperative pain while the novel analgesic ZH853 accelerates recovery and protects against latent sensitization
por: Feehan, Amy K., et al.
Publicado: (2019)

Defined Folate-PEG-siRNA Conjugates for Receptor-specific Gene Silencing
por: Dohmen, Christian, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ff6mrh2rnv43ae3oijtbacubrm